The Biophotonics market evaluations are based on an in-depth study of the key market segments, including product type, application, and regional segments, and the market’s highly competitive nature. In this report, the authors have closely discerned the primary factors influencing the global market growth, technological innovations, critical industry-verified facts and figures, and the current as well as emerging market trends.

The Global Biophotonics Market is anticipated to garner a valuation of USD 118.19 Billion by 2027, growing at a CAGR of 11.7%, as per the latest analysis by Emergen Research. The rapid advancements in optical technologies, extensive research, and the augmenting requirement for early diagnosis are potential market drivers anticipated to bolster the industry's growth during the projected timespan. Biophotonics finds numerous applications due to the remarkable ability to harness light-weight to understand the complexity of functioning cells and tissues in organisms, thereby conferring an advanced level of diagnosis.

Owing to its extensive application, the key market players are actively capitalizing on the technique to gain a robust footing in the industry. However, the market is growing at a slow pace due to the low acceptance rate, sensitivity issues, and concerns regarding reliability and quality.

Key Highlights from the Report:

The market is forecast to grow at a substantial rate owing to the rising adoption of technology across numerous industrial verticals such as biotechnology, medicine, agriculture, and other R&D areas of science.

North America is forecast to grow at a CAGR of 11.2% during the predicted span due to the growing investment in the R&D sector and the increasing cancer occurrences in the region. The augmented healthcare infrastructure development and expenditure coupled with growing initiatives from the government are anticipated to accelerate the market's growth in the area.

Key players of the industry include Affymetrix, Inc., Zecotek Photonics Inc., Andor Technology Ltd, FEI Company, Carl Zeiss AG, Hamamatsu Photonics K.K. Lumenis Ltd., and Becton, Dickinson, and Company, among others.

Technology Outlook (Revenue, USD Billion; 2017-2027)

In-vitro
In-vivo

Application Outlook (Revenue, USD Billion; 2017-2027)

Light Therapy
Microscopy
Endoscopy
Surface Imaging
Spectromolecular
Biosensors

End-User Outlook (Revenue, USD Billion; 2017-2027)

Medical Therapeutics
Medical Diagnostics
Test Components

Regional Outlook (Revenue: USD Billion; 2017-2027)

North America
S.
Canada
Mexico
Europe
K.
Germany
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
A.E.
Rest of MEA